Journal of Tissue Viability
Volume 17, Issue 2 , Pages 38-43 , May 2008

Malignant fibrous histiocytoma of the mandible in the context of a traumatic Marjolin's ulcer

  • Ali Hossein Mesgarzadeh

      Affiliations

    • Department of Oral and Maxillofacial Surgery, School of Dentistry, Tabriz University of Medical Sciences, Iran
    • ,
  • Ramin Mostofi Zadeh Farahani

      Affiliations

    • School of Dentistry, Tabriz University of Medical Sciences, Gogasht Street, Daneshgah Street, Tabriz, East Azerbaijan, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 0411 5546457; fax: +98 411 3346977.
    • ,
  • Nathaniel Treister

      Affiliations

    • Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Harvard School of Dental Medicine, Boston, MA, USA
    • Division of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA, USA

References 

  1. Ozello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer. 1963;16:331–344
  2. Hollowood K, Path MRC, Fletcher CDM. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?. Seminars in Diagnostic Pathology. 1995;12:210–220
  3. Brooks JJ. The significance of double phenotypic and markers in human sarcomas. A new model of mesenchymal differentiation. American Journal of Pathology. 1986;125:113–123
  4. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma – an analysis of 200 cases. Cancer. 1978;41:2250–2266
  5. Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of the bone. A study of 130 patients. The American Journal of Surgical Pathology. 1985;9:853
  6. Kanazawa H, Watanabe T, Kasamatsu A. Primary malignant fibrous histiocytoma of the mandible: review of literature and report of a case. Journal of Oral and Maxillofacial Surgery. 2003;61:1224–1227
  7. Kirsner RS, Spencer J, Falanga V, Garland LE, Kerdel FA. Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation. Dermatologic Surgery. 1996;22:1015–1018
  8. Kirsner RS, Garland LD. Squamous cell carcinoma arising from chronic osteomyelitis treated by Mohs micrographic surgery. The Journal of Dermatologic Surgery and Oncology. 1994;20:141–143
  9. Goldberg DJ, Arbesfeld D. Squamous cell carcinoma arising in a site of chronic osteomyelitis. Treatment with Mohs micrographic surgery. The Journal of Dermatologic Surgery and Oncology. 1991;17:788–790
  10. Abdelwahab IF, Hermann G, Lewis MM, Klein MJ. Transformation of an idiopathic bone infarct into malignant fibrous histiocytoma in a female. A case report. Bulletin of the Hospital for Joint Diseases Orthopaedic Institute. 1988;48(2):197–203
  11. Liddell K. Malignant changes in chronic varicose ulceration. The Practitioner. 1975;215:335–339
  12. Andrews BT, Stewart JB, Allum WH. Malignant melanoma occurring in chronic venous ulceration. Dermatologic Surgery. 1997;23:598–599
  13. Hill BB, Sloan DA, Lee EY, McGrath PC, Kenady DE. Marjolin's ulcer of the foot caused by nonburn trauma. The Southern Medical Journal. 1996;89:707–710
  14. Gan BS, Colcleugh RG, Scilley CG, Craig ID. Melanoma arising in a chronic (Marjolin's) ulcer. Journal of the American Academy of Dermatology. 1995;32:1058–1059
  15. Arons MS, Rodin AE, Lynch JB, Lewis SR, Blocker TG. Scar tissue carcinoma. Part II: an experimental study with special reference to bum scar carcinoma. Annals of Surgery. 1966;163:445–460
  16. Fleming MD, Hunt JL, Purdue GF, Sandstad J. Marjolin's ulcer: a review and reevaluation of a difficult problem. The Journal of Burn Care and Rehabilitation. 1990;11:460–469
  17. Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR. A case-control study of osteosarcoma in young persons. American Journal of Epidemiology. 1987;126:118–126
  18. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine. 1994;1:71
  19. Nakatani T, Marui T, Yamamoto T, Kurosaka M, Akisue T, Matsumoto K. Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma. Pathology International. 2001;51:595–602
  20. Ueda T, Araki N, Mano M, Myoui A, Joyama S, Ishiguro S, et al. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone. Journal of Clinical Pathology. 2002;55(11):853–858
  21. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology. 2001;166(12):7556–7562
  22. Kouri J, Ancheta O. Transformation of macrophages into fibroblasts. Experimental Cell Research. 1972;71:168–176
  23. Feigl W, Susani M, Ulrich W, Matejka M, Losert U, Sinzinger H. Organisation of experimental thrombosis by blood cells. Evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells. Virchows Archiv A Pathological Anatomy and Histopathology. 1985;406:133–148
  24. Kopelovich L, Wang TY. Histiocytic conversion of human adult skin fibroblasts by the Snyder–Theilen feline sarcoma virus. European Cytokine Network. 1990;1:157–168
  25. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. American Journal of Pathology. 1999;154(3):871–882
  26. Grinnell F, Zhu M, Carlson MA, Abrams JM. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Experimental Cell Research. 1999;248(2):608–619
  27. Liesveld JL, Rush S, Kempski MC, Turner AR, Brennan JK, Gasson JC, et al. Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Experimental Hematology. 1993;21(10):1342–1352
  28. Yamamoto T, Akisue T, Marui T, Fujita I, Matsumoto K, Hitora T, et al. Expression of transforming growth factor β isoforms and their receptors in malignant fibrous histiocytoma of soft tissues. Clinical Cancer Research. 2004;10(17):5804–5807
  29. Watanabe K, Ogura G. Fibronexus in “malignant fibrous histiocytoma” of the bone: a case report of pleomorphic myofibrosarcoma. Ultrastructural Pathology. 2002;26(1):47–51
  30. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. Journal of Immunology. 1998;160(1):419–425
  31. Yonemoto T, Takenouchi T, Tokita H, Tatezaki S, Mukaida N, Mikata A, et al. Establishment and characterization of a human malignant fibrous histiocytoma cell line. Clinical Orthopaedics and Related Research. 1995;320:159–167
  32. Shirasuna K, Sugiyama M, Miyazaki T. Establishment and characterization of neoplastic cells from a malignant fibrous histiocytoma. A possible stem cell line. Cancer. 1985;55(11):2521–2532
  33. Suster S, Phillips M, Robinson MJ. Malignant fibrous histiocytoma (giant cell type) of the pancreas. A distinctive variant of osteoclast-type giant cell tumor of the pancreas. Cancer. 1989;64:2303–2308
  34. Sohail D, Kerr R, Simpson RH, Babajews AV. Malignant fibrous histiocytoma of the mandible: the importance of an accurate histopathological diagnosis. British Journal of Oral and Maxillofacial Surgery. 1995;33(3):166–168
  35. Anavi Y, Herman GE, Graybill S, MacIntosh RB. Malignant fibrous histiocytoma of the mandible. Oral Surgery, Oral Medicine, and Oral Pathology. 1989;68(4):436–443
  36. Dreinhofer KE, Akerman M, Willen H, Anderson C, Gustafson P, Rydholm A. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. International Journal of Cancer. 1994;59(3):379–382
  37. Moisa II, Valdes ME, Shapiro BM. Malignant fibrous histiocytoma of the mandible. Ear, Nose, and Throat Journal. 1988;67:773
  38. Brown MD, Swanson NA. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. Journal of Dermatologic Surgery and Oncology. 1989;15(12):1287–1292
  39. Bader H, Spohner F, Gerlitzky W, Meyer D. Malignant fibrous histiocytoma after supracondylar femoral fracture. Dtsch Med Wochenschr. 1981;106(11):336–339
  40. Lindeman G, McKay MJ, Taubman KL, Bilous AM. Malignant fibrous histiocytoma developing in bone 44 years after shrapnel trauma. Cancer. 1990;66(10):2229–2232
  41. Czerwiński E, Skolarczyk A, Frasik W. Malignant fibrous histiocytoma in the course of chronic osteomyelitis. Arch Orthop Trauma Surg. 1991;111(1):58–60
  42. Laffargue P, Hildebrand HF, Lecomte-Houcke M, et al. Malignant fibrous histiocytoma of bone 20 years after femoral fracture treated by plate-screw fixation: analysis of corrosion products and their role in malignancy. Rev Chir Orthop Reparatrice Appar Mot. 2001;87(1):84–90

PII: S0268-0009(07)00010-8

doi: 10.1016/j.jtv.2007.09.012

Journal of Tissue Viability
Volume 17, Issue 2 , Pages 38-43 , May 2008

Article Tools

* Image Usage & Resolution